GGrantIndex
← Leaderboards

Michael A Bookman

Fox Chase Cancer Center

$1,846,719
Attributed
$3,117,600
Total exposure
4
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $785.4K · FY200913
$1M$750K$500K$250K$0
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$3,117,600 · 4

By mechanism

P50$2,332,728 · 2
P30$784,872 · 2

Top collaborators

Most similar at Fox Chase Cancer Center

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Trials

Research focus

Clinical TrialsBiomedical FacilityHealth Science Research Analysis /EvaluationPatient /Disease RegistryHuman DataClinical ResearchBiomedical ResourceBlood TestsBloodBiomarkerCancer PatientCancer TypeCarboplatinCellsCancer BiologyCohortBiologyBrca2 GeneClassificationCombination ChemotherapyCancer CellDefectDetectionChemotherapy

Grant awards (21)

Gene Methylation Signatures for Predictive Classification of Response to Therapy$279,486
P50 · FY2013 · CA
Gene Methylation Signatures for Predictive Classification of Response to Therapy$785,372
P50 · FY2012 · CA
Gene Methylation Signatures for Predictive Classification of Response to Therapy$289,614
P50 · FY2011 · CA
Gene Methylation Signatures for Predictive Classification of Response to Therapy$304,215
P50 · FY2010 · CA
Gene Methylation Signatures for Predictive Classification of Response to Therapy$247,635
P50 · FY2009 · CA
CORE--PROTOCOL REVIEW AND MONITORING SYSTEM$196,218
P30 · FY2002 · CA
CORE--PROTOCOL MANAGEMENT$196,218
P30 · FY2002 · CA
Pharmacokinetic models to design &optimize clinical trials in ovarian cancer$165,355
P50 · FY2002 · CA
CORE--PROTOCOL MANAGEMENT$196,218
P30 · FY2001 · CA
CORE--PROTOCOL REVIEW AND MONITORING SYSTEM$196,218
P30 · FY2001 · CA
Pharmacokinetic models to design &optimize clinical trials in ovarian cancer$165,355
P50 · FY2001 · CA
CORE--PROTOCOL REVIEW AND MONITORING SYSTEM$0
P30 · FY2001 · CA
CORE--PROTOCOL MANAGEMENT$0
P30 · FY2001 · CA
CORE--PROTOCOL MANAGEMENT$0
P30 · FY2001 · CA
CORE--PROTOCOL REVIEW AND MONITORING SYSTEM$0
P30 · FY2001 · CA
Pharmacokinetic models to design &optimize clinical trials in ovarian cancer$47,848
P50 · FY2000 · CA
Pharmacokinetic models to design &optimize clinical trials in ovarian cancer$47,848
P50 · FY2000 · CA
CORE--PROTOCOL MANAGEMENT$0
P30 · FY2000 · CA
CORE--PROTOCOL REVIEW AND MONITORING SYSTEM$0
P30 · FY2000 · CA
CORE--PROTOCOL REVIEW AND MONITORING SYSTEM$0
P30 · FY2000 · CA
CORE--PROTOCOL MANAGEMENT$0
P30 · FY2000 · CA